In vitro and in vivo functional profile characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3-carboxamido)morphinan (NAQ) as a low efficacy mu opioid receptor modulator
Keywords: NAQ; Mu opioid receptor; Opioid addiction; Antagonist; β-arrestin2 recruitment; Nalbuphine;